Xtant Medical Holdings Inc. has scheduled its Annual Meeting of Stockholders for November 7, 2025, at the offices of Fox Rothschild LLP in New York, New York. During the meeting, stockholders will vote on several key proposals. These include the election of six nominees to serve as directors until the next annual meeting, the ratification of Grant Thornton LLP as the independent registered public accounting firm for the year ending December 31, 2025, and the approval of an amendment to the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan to increase the number of shares available under the plan by 12,300,000 shares. Additionally, stockholders will vote on an advisory basis regarding the compensation of executive officers and the frequency of future advisory votes on executive compensation. Other business may also be transacted during the meeting.